The mutations in TPM2 and TPM3 genes lead to congenital myopathies—clinically and genetically heterogeneous muscle disorders that usually manifest at birth by muscle weakness and hypotension, slowly progressing over time [10]. The gene discussed is TPM2; the disease is congenital myopathy.